Navigation Links
CENER (Spain) to Acquire Equipment for Biomass Pretreatment Research
Date:7/9/2012

MILFORD, Ohio, July 9, 2012 /PRNewswire/ -- AdvanceBio Systems, LLC today announced that the National Renewable Energy Centre of Spain (CENER) selected, in a global competitive bidding process, AdvanceBio Systems' SuPR2G Bench Scale Pretreatment Reactor to conduct basic research and development work, related to the production of fermentable sugars from lignocellulose rich biomass feedstocks.

"CENER and AdvanceBio Systems intend to collaborate in CENER's R&D effort, not only in pretreatment, but also with other interrelated technologies," said Bipin Shroff, a principal of AdvanceBio Systems. "The equipment will be used for research, development and demonstration of technology related to the production of renewable energy in their newly developed Second Generation Biofuels Center located in Navarra (north Spain)."

The SuPR2G reactor will incorporate AdvanceBio Systems' latest improvements to the initial Bench Scale Reactor System delivered to The Penn State University as demonstrated on YouTube: (http://www.youtube.com/user/Bioconversion1?feature=mhee)

The SuPR2G system is designed to hydrolyze a range of agricultural feedstocks such as sugarcane, bagasse, corn stover and switchgrass. Primary research at CENER will be on wheat, straw and poplar chips. The skid-mounted package system includes an integrated steam generator and PLC with a touch-screen HMI and capabilities of Ethernet Connection to existing data acquisition systems.

"By partnering with CENER, we are contributing to the development of technology to produce cellulosic ethanol from biomass, to increase global production of renewable fuels and chemicals," stated Dale Monceaux, a principal of AdvanceBio Systems.

About AdvanceBio Systems, LLC

AdvanceBio Systems, LLC, headquartered in Cincinnati, Ohio assists and consults with clients worldwide, providing services and technologies across a broad range of bio-based industries. For more information, visit www.advancebio.com.

About CENER

The National Renewable Energy Centre (CENER) is a state-of-the-art technological center dedicated to the research, development and promotion of renewable energies within Spain and beyond. CENER operates in five areas: wind power, solar energy, biomass, energy in buildings and renewable energy grid integration.

Areas of biomass research activities in liquid biofuels production:

  • Biomass Characterization
  • Pre-treatment of lignocellulosic materials
  • Enzymatic hydrolysis & fermentation
  • Assessment of bioethanol production technologies

For more information, visit www.cener.com/en.

CONTACT: 

Bipin Shroff 513-864-6681 shroff@advancebio.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE AdvanceBio Systems, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. CeNeRx BioPharma Completes $4.85 Million Financing
2. ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
3. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
4. Neogen acquires Igenity from Merial
5. CannaBANK Acquires Rights to License PharmaSpheres Patented Growth System
6. MedPlast Acquires UPG
7. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
8. Camelot Healthcare Training Institute Acquired by Medtech
9. Amgen to Acquire Micromet
10. GeneThera, Inc. Acquires Applied Genetics, S.A.
11. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... A research team led by ... in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. The article ... coronary artery disease (CAD). Lam is an assistant professor at the Department of ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March 24, ... Maxwell Biotech Venture Fund (MBVF), today announced positive results ... to the standard drug therapy regimen in patients with ... molecule drug discovered by scientists at Sequella, Inc. ( ... of Health. A total of 140 ...
(Date:3/24/2017)... Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company ... vaccines, today announced participation at the following conferences: ... and Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at ... New York, NY . Agenus will participate in ... am: Robert B. Stein , M.D., Ph.D., President, ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
Breaking Biology Technology:
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Analysis & Trends - Industry Forecast to 2025" report to ... The ... a CAGR of around 15.1% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
Breaking Biology News(10 mins):